Germany's Regional Court of Aurich ordered BioNTech to disclose 32 categories of internal safety, toxicity, and manufacturing data regarding its Comirnaty mRNA vaccine in case 5 O 1106/24. The partial judgment mandates the release of detailed records on lipid nanoparticles, spike protein behavior, genotoxicity, and pharmacovigilance findings to a plaintiff alleging severe post-vaccination injuries.
Building on a March 2026 Federal Court of Justice precedent, the ruling affirms that injured individuals have a right to access manufacturer-held data to assess causation and challenge safety claims. While the court did not determine liability, the order forces BioNTech to provide all known effects and side effects, addressing a critical imbalance in vaccine injury litigation.
https://substack.com/@jonfleetwood/note/p-194306000?r=4csp6z&utm_medium=ios&utm_source=notes-share-action
Обсуждение 6
Обсуждение не доступно в веб-версии. Чтобы написать комментарий, перейдите в приложение Telegram.
Обсудить в Telegram